Revisiting AML single-cell datasets in BBrowser to learn how monocytic AML survives Venetoclax
![](https://blog.bioturing.com/wp-content/uploads/2020/07/Blog-1.png)
Acute myeloid leukemia (AML) happens when the myeloid precursor cells in the bone marrow grow abnormally (making upĀ myeloblasts). A common treatment for AML is Venetoclax. This drug inhibits BCL2, an oncoprotein that prevents cell death and is often overexpressed in the majority of blasts from AML patients (Bensi et […]